NVO Novo Nordisk A/S

38.15USD-0.07%Mkt Cap: 168.54B $P/E: 9.33

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare D…

Key Statistics

Company
Market Cap168.54B USD
Enterprise Value264.56B USD
Revenue (TTM)329.43B USD
Gross Profit250.28B USD
Net Income (TTM)102.43B USD
Revenue/Share74.19 USD
Last Price38.15 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees66.7K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)9.33
P/E (Forward)11.48
PEG4.33
EV/EBITDA1.52
EV/Revenue0.80
P/S0.51
P/B5.08
EPS (TTM)4.09
EPS (Forward)3.32
52W Range
35.1210% of range64.16
52W High64.16 USD
52W Low35.12 USD
Profitability
Gross Margin80.98%
Oper. Margin42.54%
EBITDA Margin52.72%
Profit Margin33.14%
ROE52.79%
ROA18.87%
Growth
Revenue Growth2.10%
Earnings Growth-20.60%
Cash Flow & Leverage
Operating CF119.10B USD
CapEx (TTM)90.11B USD
FCF Margin11.44%
FCF Yield22.35%
Net Debt95.14B USD
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity0.67
Current Ratio0.87
Quick Ratio0.64
Book Value/Sh7.52 USD
Cash/Share10.16 USD
Dividends
Fwd Div Rate1.80 USD
Trail. Div Rate11.70 USD
Div. Yield4.70%
5Y Avg Yield1.49%
Payout Ratio45.09%
Ex-Div DateAug 17, 2026
Pay DateAug 25, 2026
Splits
Last Split2:1
Split DateSep 20, 2023
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)46.15 USD
Upside (mean)+21.0%
Target Range39.84 USD – 61.93 USD
39.84+21.0% to mean61.93
# Analysts12
Ownership
Shares Out.3.34B
Float3.17B
Insiders0.00%
Institutions9.89%
Short Interest
Short Ratio2.5d
Short % Float0.83%
Short % Out.0.60%
Shares Short26.34M
Short (prev mo.)33.83M
Technical
SMA 5043.96 (-13.2%)
SMA 20045.50 (-16.1%)
Beta0.38
S&P 52W Chg15.84%
Avg Vol (30d)12.83M
Avg Vol (10d)14.15M
Technical Indicators
RSI (14)34.2
MACD-1.8954
MACD Signal-1.9894
MACD Hist.+0.0940
BB Upper44.19 USD
BB Middle39.66 USD
BB Lower35.13 USD
BB Width22.84%
ATR (14)0.9998 USD
Vol Ratio (20d)0.76x